Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer

Journal of Surgical Oncology

Volumn 109, Issue 5, 2014, Pages 478-482

  Gao, Yuan Hong ^a   An, Xin ^a   Sun, Wei Jiang ^a   Cai, Juan ^a,b   Cai, Mu Yan ^a   Kong, Ling Heng ^a,b   Lin, Jun Zhong ^a,b   Liu, Guo Chen ^a,b   Tang, Jing Hua ^a,b   Wu, Xiao Jun ^a,b   Chen, Gong ^a,b   Pan, Zhi Zhong ^a,b   Ding, Pei Rong ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Chaozhou Central Hospital Affiliated to Southern Medical University   (China)

Author keywords

capecitabine; chemoradiotherapy; induction chemotherapy; oxaliplatin; rectal cancer

Indexed keywords

CAPECITABINE; OXALIPLATIN;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIARRHEA; DISTANT METASTASIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HAND FOOT SYNDROME; HUMAN; ILEUS; INDUCTION CHEMOTHERAPY; LEUKOPENIA; MALE; METASTASIS RESECTION; MIDDLE AGED; NAUSEA; PERINEUM INJURY; PERIPHERAL NEUROPATHY; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADICAL RESECTION; RADIOFREQUENCY ABLATION; RADIOTHERAPY UNIT; RECTUM CANCER; RECTUM RESECTION; SURGICAL INFECTION; THROMBOCYTOPENIA; VOMITING; WOUND DEHISCENCE; YOUNG ADULT;

CAPECITABINE; CHEMORADIOTHERAPY; INDUCTION CHEMOTHERAPY; OXALIPLATIN; RECTAL CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CHINA; DATABASES, FACTUAL; DEOXYCYTIDINE; DIARRHEA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROCTITIS; RADIODERMATITIS; RECTAL NEOPLASMS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84897027240     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23516     Document Type: Article

References (30)

1. Peeters KC, Marijnen CA, Nagtegaal ID, et al.: The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
2. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
3. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
4. Gerard A, Buyse M, Nordlinger B, et al.: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208: 606-614.
5. The evaluation of low dose pre-operative X-ray therapy in the management of operable rectal cancer; results of a randomly controlled trial. Br J Surg 1984; 71: 21-25.
6. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
7. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
8. Gerard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T 3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
9. Rodel C, Liersch T, Hermann RM, et al.: Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 2007; 25: 110-117.
10. Fernandez-Martos C, Pericay C, Aparicio J, et al.: Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 2010; 28: 859-865.
11. Chau I, Brown G, Cunningham D, et al.: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674.
12. Rodel C, Liersch T, Becker H, et al.: Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012; 13: 679-687.
13. Bria E, Gralla RJ, Raftopoulos H, et al.: Comparing two methods of meta-analysis in clinical research-Individual patient data-based (IPD) and literature-based abstracted data (AD) methods: Analyzing five oncology issues involving more than 10,000 patients in randomized clinical trials (RCTs). J Clin Oncol 2007; 25: abstr 6512.
14. Zampino MG, Magni E, Leonardi MC, et al.: Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2009; 75: 421-427.
15. Habr-Gama A, Perez RO, Sabbaga J, et al.: Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: Results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009; 52: 1927-1934.
16. Garcia-Aguilar J, Smith DD, Avila K, et al.: Optimal timing of surgery after chemoradiation for advanced rectal cancer: Preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 2011; 254: 97-102.
17. Chua YJ, Barbachano Y, Cunningham D, et al.: Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial. Lancet Oncol 2010; 11: 241-248.
18. Rodel C, Arnold D, Becker H, et al.: Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer: Is it time for a randomized phase III trial ? Strahlenther Onkol 2010; 186: 658-664.
19. Dworak O, Keilholz L, Hoffmann A:, Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23.
20. Edge SB, Byrd DR, Compton CC, editors. AJCC cancer staging manual. New York, NY: Springer; 2010.
21. Haller DG, Tabernero J, Maroun J, et al.: Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011; 29: 1465-1471.
22. Aschele C, Cionini L, Lonardi S, et al.: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011; 29: 2773-2780.
23. Hofheinz R, Wenz FK, Post S, et al.: Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. J Clin Oncol 2011; 29: abstr 3504.
24. Gerard JP, Azria D, Gourgou-Bourgade S, et al.: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28: 1638-1644.
25. Roh MS, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27: 5124-5130.
26. Ofner D, Devries AF, Schaberl-Moser R, et al.: Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT(3)NxM0, low rectal cancer: A phase II study. Strahlenther Onkol 2011; 187: 100-107.
27. An X, Lin X, Wang FH, et al.: Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis. Eur J Cancer 2013; 49: 843-851.
28. Lee WS, Yun SH, Chun HK, et al.: Clinical usefulness of chest radiography in detection of pulmonary metastases after curative resection for colorectal cancer. World J Surg 2007; 31: 1502-1506.
29. Roh MS, Yothers GA, O'Connell MJ, et al.: The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum. J Clin Oncol 2011; 29: abstr 3503.
30. Maas M, Nelemans PJ, Valentini V, et al.: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.